147 related articles for article (PubMed ID: 36118)
1. Cardiovascular effects of prenalterol (H133/22) in normal man.
Scott DH; Arthur GR; Boyes RN; Scott DB
Br J Clin Pharmacol; 1979 Apr; 7(4):365-70. PubMed ID: 36118
[TBL] [Abstract][Full Text] [Related]
2. Circulatory response to prenalterol in normal subjects and in patients with primary congestive cardiomyopathy.
Guazzi MD; Qing LG; Olivari MT; Fiorentini C; Loaldi A; Bartorelli A; Moruzzi P; Polese A
Acta Med Scand Suppl; 1982; 659():233-50. PubMed ID: 6127892
[TBL] [Abstract][Full Text] [Related]
3. Dose-response relationship in normal subjects of prenalterol, a beta-adrenergic agonist with positive inotropic and resistance lowering effects.
Rasmussen S; Høilund-Carlsen PF; Hesse B; Hartling OJ; Fabricius J; Dige-Petersen H; Giese J
Eur J Clin Pharmacol; 1984; 27(5):539-43. PubMed ID: 6151507
[TBL] [Abstract][Full Text] [Related]
4. The hemodynamic actions of prenalterol in left ventricular failure.
Awan NA; Evenson MK; Needham KE; Mason DT
Acta Med Scand Suppl; 1982; 659():251-61. PubMed ID: 6127893
[TBL] [Abstract][Full Text] [Related]
5. Haemodynamic effects of prenalterol in patients with severe congestive heart failure--NYHA III-IV.
Erbel R; Meyer J; Schweizer P; Lambertz H; Voelker W; Effert S
Acta Med Scand Suppl; 1982; 659():169-80. PubMed ID: 6127887
[TBL] [Abstract][Full Text] [Related]
6. Prenalterol as an antidote to massive doses of metoprolol--a cardiovascular study in the dog.
Andersson T; Heath A; Mattsson H
Acta Med Scand Suppl; 1982; 659():71-88. PubMed ID: 6127900
[No Abstract] [Full Text] [Related]
7. Interaction in healthy volunteers between prenalterol, a selective beta 1-adrenoceptor agonist, and metoprolol or propranolol.
Rönn O; Johnsson G; Lundborg P
J Cardiovasc Pharmacol; 1981; 3(3):477-84. PubMed ID: 6168829
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic assessment of prenalterol: a cardioselective beta agonist in patients with imparied left ventricular function.
Klein W; Brandt D; Maurer E
Clin Cardiol; 1981; 4(6):325-9. PubMed ID: 6120057
[TBL] [Abstract][Full Text] [Related]
9. Central and peripheral haemodynamic effects of prenalterol in patients with coronary heart disease.
Svendsen TL; Carlsen JE; Hartling OJ; Trap-Jensen J
Clin Physiol; 1981 Oct; 1(5):461-9. PubMed ID: 7199993
[TBL] [Abstract][Full Text] [Related]
10. Haemodynamic effects and pharmacokinetics of a new selective beta1-adrenoceptor agonist, prenalterol, and its interaction with metoprolol in man.
Rönn O; Graffner C; Johnsson G; Jordö L; Lundborg P; Wikstrand J
Eur J Clin Pharmacol; 1979 Feb; 15(1):9-13. PubMed ID: 33811
[TBL] [Abstract][Full Text] [Related]
11. The cardiovascular effects of xamoterol, a beta 1-adrenoceptor partial agonist, in healthy volunteers at rest.
Hashimoto T; Shiina A; Toyo-Oka T; Hosoda S; Kondo K
Br J Clin Pharmacol; 1986 Mar; 21(3):259-65. PubMed ID: 2421751
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic and cardiometabolic effects of prenalterol in patients with gram negative septic shock.
Reiz S; Friedman A
Acta Anaesthesiol Scand; 1980; 24(1):5-10. PubMed ID: 7376804
[TBL] [Abstract][Full Text] [Related]
13. Haemodynamic effects, plasma concentrations and tolerance of orally administered prenalterol in man.
Weiss A; Pfister B; Imhof P; Degen PH; Burckhardt D; Dubach UC
Eur J Clin Pharmacol; 1980 Nov; 18(5):383-90. PubMed ID: 6108221
[No Abstract] [Full Text] [Related]
14. Haemodynamic and cardiac metabolic effects of the new beta 1 agonist prenalterol in patients with cardiac failure.
Kupper W; Schütt M; Hamm CW; Kuck KH; Hanrath P; Bleifeld W
Eur Heart J; 1983 Aug; 4(8):573-83. PubMed ID: 6139281
[TBL] [Abstract][Full Text] [Related]
15. Immediate central and regional haemodynamic effects of a new beta 1-adrenergic stimulating drug, xamoterol (Corwin) in healthy volunteers.
Tangø M; Carlsen JE; Trap-Jensen J
Eur J Clin Pharmacol; 1985; 29(2):155-8. PubMed ID: 2866963
[TBL] [Abstract][Full Text] [Related]
16. The haemodynamic effects of dopamine and prenalterol in patients after cardiac valve surgery.
Tydén H; Johansson L; Nyström SO
Acta Anaesthesiol Scand; 1982 Oct; 26(5):468-73. PubMed ID: 6128857
[TBL] [Abstract][Full Text] [Related]
17. Effect of intravenous prenalterol on haemodynamics and myocardial lactate extraction in patients with left ventricular failure.
Kupper W; Schütt M; Bleifeld W
Acta Med Scand Suppl; 1982; 659():287-98. PubMed ID: 6127895
[TBL] [Abstract][Full Text] [Related]
18. Cardio-selective beta adrenergic stimulation with prenalterol in the conscious dog.
Manders WT; Vatner SF; Braunwald E
J Pharmacol Exp Ther; 1980 Oct; 215(1):266-70. PubMed ID: 6109017
[TBL] [Abstract][Full Text] [Related]
19. Interaction of rapid nongenomic cardiovascular aldosterone effects with the adrenergic system.
Schmidt BM; Georgens AC; Martin N; Tillmann HC; Feuring M; Christ M; Wehling M
J Clin Endocrinol Metab; 2001 Feb; 86(2):761-7. PubMed ID: 11158043
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the hemodynamic effects of prenalterol and isoprenaline in patients with complete heart block.
Svendsen TL; Pelle H; Lønholt C; Bonde J; Kampmann JP; Lindeneg O
J Cardiovasc Pharmacol; 1984; 6(4):693-6. PubMed ID: 6206327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
